Purdue Pharma’s Sackler family owners have struck a new agreement to settle mass opioid litigation against them for a total ...

Members of the family who own OxyContin maker Purdue Pharma, and the company itself, agreed to pay up to $7.4 billion in a ...

NEW YORK (Reuters) -Purdue Pharma and its Sackler family owners have reached a new $7.4 billion settlement to resolve thousands of lawsuits alleging that the pain medication OxyContin caused a ...

New York Attorney General Letitia James announced Thursday a new $7.5 billion settlement with Purdue Pharmaceuticals and the Sackler Family for their role in the ongoing US opioid crisis, with the ...

Purdue was instrumental in creating the US opioid crisis via aggressive marketing that did not reflect the true addiction risks of its drugs, particularly OxyContin (oxycodone). Many other creditors ...

The deal comes after the Supreme Court blocked a controversial bankruptcy plan for Purdue that shielded Sackler family ...

Purdue Pharma and its Sackler family owners ... OxyContin caused a widespread opioid addiction crisis in the U.S., several state attorneys general said Thursday. The settlement was announced ...

Purdue Pharma and its Sackler family owners ... Oxycontin caused a widespread opioid addiction crisis in the US, Texas attorney general Ken Paxton said Thursday. The settlement was announced ...

Texas and 14 other states have secured a $7.4 billion settlement from the Sackler family and their company Purdue Pharma for their roles in creating the opioid crisis. Purdue Pharma was the ...

Purdue Pharma and the Sackler families agreed Thursday to increase their financial contribution to $7.4 billion to resolve mass opioid litigation.

Purdue Pharma and the Sackler family who controlled it have agreed to pay up to $7.4bn (£6bn) to settle claims regarding its powerful prescription painkiller OxyContin. The deal represents an increase ...